Carolyn L. Bigelow, MD
Professor-Clinical
Department:
SOM-Medicine-HEM
Email:
cbigelow@umc.edu
Work Phone:
(601) 984-5615
Education
| Rhodes College, BS | |
| University of Mississippi School of Medicine, MD, Medicine | |
| VA Hospital, Research, Division of Hematology/Oncology | |
| University of Mississippi School of Medicine, Internal Medicine | |
| University of Mississippi School of Medicine, Internal Medicine | |
| University of Washington, Division of Hematology/Oncology |
Specialty Certification Licensure
| Certification, Hematology, American Board of Internal Medicine | 1988 - Present |
| Certification, Internal Medicine, American Board of Internal Medicine | 1982 - Present |
| Licensure, Medical Licensure, MS Board of Medical Licensure | 1979 - Present |
Current Positions
| Section Chief, School of Medicine, Department of Medicine | 2013 - Present |
| Professor, School of Medicine, Department of Medicine | 2004 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 1996 - 2004 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 1988 - 1996 |
| Instructor, University of Washington, School of Medicine, Department of Medicine | 1987 - 1988 |
Sponsored Program Funding
| Extramural, Adult Sickle Cell Hemoglobinopathy Program, Mississippi State Department of Health | 03/2013 - 06/2013 |
| Extramural, Basic and Translational Research Program (BTRP) in Sickle Cell Disease, National Institutes of Health/National Heart | 04/2009 - 09/2009 |
| Extramural, Osiris Therapeutics, Osiris Therapeutics, Inc. | 05/2008 - 06/2010 |
| Extramural, Osiris Therapeutics, Osiris Therapeutics, Inc. | 03/2007 - 09/2009 |
| Extramural, Icagen, Icagen, Inc. | 05/2005 - 05/2008 |
| Extramural, Arginine Supplementation in Sickle Cell Anemia, National Institutes of Health | 07/2004 - 07/2007 |
| Extramural, Icagen, Icagen, Inc. | 05/2003 - 04/2004 |
| Extramural, Comprehensive Sickle Cell Center, National Institutes of Health | 04/2003 - 03/2008 |
| Extramural, Boston Comprehensive Sickle Cell Center - Clinical Core A, National Institutes of Health | 03/2003 - 03/2008 |
| Extramural, Multicenter Study of Hydroxyurea (MSH) Patients Follow-up Extension 1, National Heart, Lung, and Blood Institute | 12/2002 - 12/2007 |
| Extramural, Genetic Modulation of Sickle Cell Anemia, National Institutes of Health | 09/2001 - 07/2006 |
| Extramural, Icagen, Icagen, Inc. | 06/2001 - 06/2002 |
| Extramural, Mississippi Educational Initiative for Stem Cell Transplantation, National Marrow Donor Program | 02/2001 - 01/2003 |
| Extramural, Comprehensive Sickle Cell Centers, National Institutes of Health | 04/2000 - 03/2003 |
| Extramural, Multicenter Study of Hydroxyurea (MSH) in Sickle Cell Anemia, National Heart, Lung, and Blood Institute | 02/1996 - 06/2003 |
| Extramural, Clinical Research Protocol on Antiemetics for Chemotherapy, Pharmaco Dynamics Research, Inc. | 01/1992 - 12/1993 |
| Intramural, Hyperlipidemia and Cellular Production of Proteoglycans, University of Mississippi | 01/1990 - 12/1991 |
| Extramural, Hematopoietic Cells and LDL Metabolism, National Institutes of Health | 01/1986 - 12/1991 |
Publications
Journal Article | |
| Baker, KS, Davies SM, NMajhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, et.al Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation Biol Blood Marrow Transplant 15:1543-1554, 2009 | 2009 |
| Steinberg MH, Bigelow CL, et al Effect of Hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment JAMA 289 (13) 1645-1651, April, 2003 | 2003 |
| Van derJagt RHC, Appelbaum FR, Petersen FB, Bigelow CL, Fisher LD, Schoch GH, Buckner CD, Sanders JE, Storb R, Sullivan KM, Thomas ED Busulfan and Cyclophosphamide as a Preparative Regimen for Bone Marrow Transplantation in Patients with Prior Chest Radiotherapy Bone Marrow Transplantation (8) 211-215, 1991 | 1991 |
| Bigelow, CL, Adler LT, Appelbaum FR Impact of RLA Matching and Cyclosporine on Long-Term Survival in Transplanted Rabbits Exp Hematol 18:3-6, 1990 | 1990 |
| Bowden RA, Coombs RW, Nikora BH, Bigelow CL, Sale GE, Thomas ED, Meyers JD, Corey L Progression of Human Immunodeficiency Virus Type-1 Infection After Allogeneic Marrow Transplantation The Am J of Med 88: 5-49N-5-53N, 1990 | 1990 |
| Petersen FB, Appelbaum FR, Hill R, Fisher LD, Bigelow CL, Sanders JE, Sullivan KM, Bensinger WI, Witherspoon RP Storb R. Autologous Marrow Transplantation for Malignant Lymphoma: A Report of 101 Cases from Seattle J of Clin Onc 8(4):638-647, Apr 1990 | 1990 |
| Petersen FB, Appelbaum FR, Bigelow CL, Buckner CD, Clift RA, Sanders JE, Storb R, Sullivan KM, Weiden PL, Fefer A High-dose Cytosine Arbinoside, Total Body Irradiation and Marrow Transplantation for Advanced Malignant Lymphoma Bone Marrow Transplantation 4(5): 483-88, 1989 | 1989 |
| Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED: Influence of Acute and Chronic Graft-Versus-Host Disease on Relapse and Survival After Bone Marrow Transplantation from HLA-Identical Siblings as Treatment of Acute and Chronic Leukemia Blood 73:1720-1728, 1989 | 1989 |
| Bigelow CL, Wight TN. Altered Proteoglycan and Hyaluronic Acid Metabolism in LDL Receptor Deficient Cultured Bone Marrow Cells J Cell Bio 107:883, 1988 | 1988 |
| Bigelow CL, Adler L, Appelbaum FR: Allogeneic Bone Marrow Transplantation in Irradiated Adult Rabbits Transplantation 44:351-354, 1987 | 1987 |
| Bigelow CL, Tavassoli M: Fatty Involution of Bone Marrow in Rabbits. Acta Anat 118:60-64, 1984 | 1984 |
| Bigelow CL, Tavassoli M: Studies on Conversion of Yellow Marrow to Red Marrow by Using Ectopic Bone Marrow Implants Exp Hematol 12:581-585, 1984 | 1984 |
| Baker KS, Hassebroek A, Ballen K, Bigelow C, Frangoul H, Hardy C, Lee S, Switzer G, Rizzo JD, Kein JP, Majhail N, Davies S Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transaplantaion (HcT) Blood. 2007; 110:901A | 2007 |
| Bigelow C, Elkins S, Hardy C, Files J Variable intensity conditioning with durable engraftment and less graft versus host disease J Invest Med 52(1): S272, January, 2004 | 2004 |
| McCollum A, Bigelow CL, Elkins SL, Hardy CL, Files JC Unusual skin lesions in chronic myelomonocytic leukemia South Med J 96 (7): 681-684, July, 2003 | 2003 |
| Byers T, Vance R, Bigelow, C High-Dose Chemotherapy for Breast Cancer? Cancer Practice 8 (2) 96-98, 2000 | 2000 |
| Bigelow CL, Kopecky K, Files JC, Head D, Lipschitz DA, Greever M, Appelbaum FR Treatment of Acute Myelogenous Leukemia in Patients Over 50 years of Age with V-TAD: A Southwest Oncology Group Study Am J of Hem (48) 228-232, 1995 | 1995 |
| Bigelow CL, Files JC Bone Marrow Transplantation: A New Treatment Approach for Mississippians Journal MSMA , 205-208, June, 1991 | 1991 |
| Appelbaum F, Bigelow C: Managing the Bone Marrow Transplant Patient. (Monograph) In: Critical Decisions in Medicine, New York Eli Lilly & Co, Park Row Publishers, 1987, pp 1-8 | 1987 |
Abstracts | |
| Bigelow C, Elkins S, Hardy C, Files J Allotransplantation with reduced intensity conditioning that includes alemtuzumab lessens incidence of relapse and transplant-related mortality in patients with high-risk myeloid diseases J Invest Med 54(1):5272, 2006 | 2006 |
| Bigelow C, Elkins S, Hardy C, Files J Allotransplantation with reduced intensity conditioning that includes alemtuzumab lessens transplant-related mortality and incidence of relapse in patients with high-risk myeloid diseases Biol Blood Marrow Trans 12:46, 2006 | 2006 |
| Bigelow CL, Elkins SL, Hardy CL, Files JC Allotransplantation with reduced intensity conditioning regimens modified to lessen transplant-related mortality is a useful treatment for high risk myeloid diseases Blood 106:417b, 2005 | 2005 |
| Bigelow CL, Elkins S, Hardy Cl, Files JC Less transplant-related mortality with variable intensity conditioning than non-myeloablative conditioning in unrelated and related adult allogeneic transplant recipients Biol Blood Marrow Transp 11:34, 2005 | 2005 |
| Bigelow C, Elkins S, Hardy C, Files J Variable intensity conditioning is associated with less transplant-related mortality than non-myeloablative conditioning in unrelated and related allogeneic transplant recipients J Invest Med 53(1): S276, January, 2005 | 2005 |
| Bigelow C, Elkins S. Hardy C, Files J Less transplant related mortality with variable intensity conditioning in unrelated ad related adult allogeneic transplant recipients Blood 104:345b, 2004 | 2004 |
| Steinberg M, Nolan V, Baldwin C, Wyszynski D, Amirault Y, Farrell J, Bisbee A, Bigelow C, Iyer R, Gavras H, Gallagher D, Farrer L Association of polymorphisms in genes of the transforming growth factor (TGF)-B pathway with sickle cell osteonecrosis Blood 102(11): 262a, November 16, 2003 | 2003 |
| Bigelow CL, Elkins S, Megason GC, Hardy CL, Files JC Effect on platelet and neutrophil recovery of administration of filgrastim post transplant in autologous transplant recipients Blood 102(11): 438b, November 16, 2003 | 2003 |
| Bigelow C, Elkins S, Hardy C, Files J Outcomes of unrelated PBSCT transplantation in adult Caucasian and African American patients: one center’s experience J Invest Med 51:S264, 2003 | 2003 |
| 27. Steinberg M, Baldwin C, Wyszynski D, Nolan V, Amirault Y, Farrell J, Bisbee A, Adams R, Gavras H, Gallagher D, Bigelow C, Iyer R, Farrer L Stroke in sickle cell anemia: association of single nucleotide polymorphisms in genes affecting vascular function Blood 102(11):119a, November 16, 2003 | 2003 |
| Bigelow C, Elkins S, Hardy C, Files J Variable intensity conditioning with durable engraftment and less graft versus host disease in recipients of unrelated and related transplants Blood 102(11): 428b, November 16, 2003 | 2003 |
| van derJagt RHC, Appelbaum FR, Petersen FB, Bigelow CL, Buckner CD, Sanders J, Storb R, Sullivan KM, Thomas ED. Busulfan and Cyclophosphamide as a Preparative Regimen for Bone Marrow Transplantation in Patients with Prior Chest Radiotherapy Blood 74 (Suppl 1) : 164a, 1989 | 1989 |
| Petersen FB, Bigelow C, Appelbaum FR, Buckner CD, and the Seattle Marrow Transplant Group. Treatment of Malignant Lymphoma with Autologous Marrow Transplantation Exp Hematol 16:493, 1988 | 1988 |
| Petersen FB, Bigelow C, Appelbaum FR, Buckner CD, and the Seattle Marrow Transplant Group. Treatment of Malignant Lymphoma with Autologous Marrow Transplantation Marrow Transp 3 (1): 64, 1988 | 1988 |
Book Chapter | |
| Sullivan KM, Witherspoon RP, Storb R, Anasetti C, Appelbaum FR, Bigelow C, Clark J, Doney K, Hill R, Loughran T, Matthews DD, Nims J, Petersen F, Sanders J, Schuning F, Shields A, Strom S, Thomas ED Chronic Graft-Versus-Host Disease: Recent Advances in Diagnosis and Treatment. In: Bone Marrow Transplantation, Alan R. Liss Inc. 1989, pp 511-522 | 1989 |
| Sullivan K, Witherspoon R, Storb R, Appelbaum FR, Beatty R, Bensinger W, Bigelow C, Buckner D, Cheever M, Clift RA Doney K, Fefer A, Greenberg P, Hansen J, martin P, Matthews D, McDonald G, Meyers J, Peterson FB, Sanders J, Shulman H, Signer J, Stewart P, and Thomas DE: Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors IN: Experimental Hematology Today, Springer-Verlag, New York, 1987. | 1987 |
| Sullivan K, Witherspoon R, Storb R, Appelbaum FR, Beatty R, Bensinger W, Bigelow C, Buckner D, Cheever M, Clift RA, Doney K, Fefer A, Greenberg P, Hansen J, Martin P, Matthews D, McDonald G, Meyers J, Petersen FB, Sanders J, Shulman H, Singer J, Stewart P, and Thomas DE: Chronic Graft-Versus-Host Disease Pathogenesis, Diagnosis, Treatment, and Prognostic Factors. In: Experimental Hematology Today Springer-Verlag, New York, 1987 | 1987 |
Presentations
| Regional Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Jackson Tennessee, Jackson, TN | 05/2013 |
| Regional Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, South Arkansas Hematology/Onocology, Pine Bluff, AR | 05/2013 |
| Regional Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Clopton Clinic Oncology, Jonesboro, AR | 05/2013 |
| State/Local Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Family Cancer Center-Oxford, Oxford, MS | 05/2013 |
| Regional Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Little Rock Hematology/Oncology, North Little Rock, AR | 05/2013 |
| State/Local Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Columbus Golden Triangle-Satellite Office, Starkville, MS | 04/2013 |
| State/Local Invited Seminars/Lectures, aHUS: Disease and Diagnosis, Ruth's Chris Steak House, Ridgeland, MS | 03/2013 |
| State/Local Invited Seminars/Lectures, aHUS: Disease and Diagnosis, Jazzeppi's, Biloxi, MS | 02/2013 |
| State/Local Invited Seminars/Lectures, aHUS: Disease and Diagnosis, Singing Pines Cancer Center, Ocean Springs, MS | 02/2013 |
| State/Local Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Columbus Hematology Oncology, Columbus, MS | 01/2013 |
| State/Local Invited Seminars/Lectures, Overview of Kyprolis (carfilzomib) for injection, Anderson Medical Center, Cancer Registry, Meridian, MS | 01/2013 |
| Regional Invited Seminars/Lectures, A New Perspective in the Treament of Multiple Myeloma: The Role of Subcutaneous VELCADE, Dothan Hematology Oncology, Dothan, AL | 11/2012 |
| State/Local Invited Seminars/Lectures, Treatment for aHUS, AJ's Seafood and Steaks, Flowood, MS | 10/2012 |
| State/Local Invited Seminars/Lectures, Treatment for aHUS, Mesquite Chop House, Southaven, MS | 08/2012 |
| State/Local Invited Seminars/Lectures, Acute Leukemia, Mississippi College Physician's Assistant Program/University of Mississippi Medical Center, Jackson, MS | 03/2012 |
| State/Local Invited Seminars/Lectures, Leukemia, Mississippi Cancer Registrars Association/University of Mississippi Medical Center, Jackson, MS | 03/2012 |
| Invited Symposia, Hemoglobinopathy, Anemias (Sickle Cell Anemia, Thalassemia, G6PD Deficiency, Mississippi College Physician's Assistant Program, Jackson, MS | 02/2012 |
| Invited Symposia, Coagulation Disorders (Hemophilia), Mississippi College Physician's Assistant, Jackson, MS | 02/2012 |
| Invited Symposia, A Clinical Discussion on Arzerra (ofatumumab) Injection, Nurses, Nurse Practitioners, and Pharmacistis, Jackson, MS | 12/2011 |
| Invited Symposia, A Clinical Discussion on Arzerra (ofatumumab) Injection, Family Cancer Clinic and Pharmacist from Baptist Hospital Oxford, Oxford, Mississippi | 12/2011 |
| Invited Symposia, A Perspective in the Treatment of Previously Untreated Multiple Myeloma, Northeast Georgia Diagnostic Clinic/Gainesville Hematology/Oncology, Gainesville, Georgia | 10/2011 |
| Invited Symposia, The Role of Velcade in Previously Untreated Multiple Myeloma, Mississippi Nursing Society, Ridgeland, Mississippi | 09/2011 |
| Invited Symposia, A Clinical Disscussion on Arzerra Injection, Oncology Cancer Center of Kansas, Wichita, Kansas | 06/2011 |
| Invited Symposia, Understanding Clinical Outcomes in Previously Untreated Multiple Myeloma, Meridian Oncology Associates, Meridian, Mississippi | 06/2011 |
| Invited Symposia, Update in the Treatment of Refractory Chronic Lymphocytic Leukemia, Hutchinson Oncology Assoicates, Hutchinson, Kansas | 11/2010 |
| State/Local Invited Seminars/Lectures, Optimizing Therapy for Indolent Lymphoma, Anderson Tumor Board, CBCE, Meridian, Mississippi | 09/2010 |
| Invited Symposia, Update in the Treatment of Refractory Chronic Lymphocytic Leukemia, Charleston Hematology Oncology Associates, Charleston, South Carolina | 04/2010 |
| Invited Symposia, Update in the Treatment of Refractory Chronic Lymphocytic Leukemia, Central Georgia, Warner Robins, Georgia | 04/2010 |
| State/Local Invited Seminars/Lectures, Advances in the Treatment of Multiple Myeloma, Mississippi Oncology Nursing Society, Ridgeland, Mississippi | 03/2010 |
| National and International Invited Seminars/Lectures, New Therapies for Relapsed B-Cell Lymphoma, CME Presentation for Scott White Clinic, Temple, Texas | 06/2009 |
| State/Local Invited Seminars/Lectures, The Role of Revlimid in Multiple Myeloma, Laurel, Mississippi | 03/2009 |
| Invited Symposia, Leukemia, Jennie Duvall Oncology Nursing Update, University of Mississippi Medical Center, Jackson, Mississippi | 03/2009 |
| Scientific Presentations, A case report of mycosis fungoides evolving into an aggressive cutaneous T-cell lymphoma, Southern Society for Clinical Investigation, New Orleans, LA | 02/2009 |
| State/Local Invited Seminars/Lectures, Myelodysplasia Current Trends, Leukemia Society, Jackson Oncology Associates, Jackson, Mississippi | 11/2008 |
| Invited Symposia, Emerging Agents in the Treatment of Relapsed/Refractroy Indolent Lymphoma, Alabama Oncology Nursing Society, Mobile, Alabama | 11/2008 |
| Invited Symposia, The role of revlimid in multiple myeloma and vidaza for the management of MDS, local physicians, Meridian, MS | 10/2008 |
| Invited Symposia, Emerging Agents in the Treatment of Relapsed/Refractory Indolent Lymphomas, Mississippi Oncology Nursing Society, St. Dominic Hospital, Jackson, Mississippi | 09/2008 |
| Invited Symposia, Emerging agetns in the treatmetn indolent relapsed or refractory non-Hodgkin's lymphoma, Memphis, TN | 08/2008 |
| Invited Symposia, Sickle Cell Disease: Managing Complications of Sickle Cell Disease, Sickle Cell Conference, Jackson Medical Mall Thad Cochran Center, Jackson, Mississippi | 05/2008 |
| Invited Symposia, The role of Revlimid in multiple myeloma, Mobile, AL | 03/2008 |
| National and International Invited Seminars/Lectures, Impact of ethnicity and socioeconomic status on outcome of unrelated donor (URD) hematopoietic cell transplantation (HcT), American Society of Hematology, Atlanta, GA | 12/2007 |
| Grand Rounds, Advances in anticoagulation for the management of venous thromboembolic disease and heparin-induced thrombocytopenia, South Central medical Center, Laurel, MS | 11/2007 |
| CME Luncheon, Atherothrombosis: antiplatelet and anticoagulant therapy, Rush Foundation Hospital, Meridian, MS | 10/2007 |
| Workshop, Multiple myeloma, Celgene Tumor Board Workshop, St. Pete Beach, FL | 10/2007 |
| Invited Symposia, The management and treatment options for deep vein thrombosis, Advanced Health Media, Bilox, MS | 05/2007 |
| Invited Symposia, Reduced intensity conditioning using alemtuzumab in allogeneic hematopoietic transpalantation, Southern Society for Clinical Investigation, New Orleans, LA | 02/2007 |
| Invited Symposia, Thromboembolism in multiple myeloma patients receiving thalidomide combination chemotherapy, Southern Society for Clinical Investigation, New Orleans, LA | 02/2007 |
| Poster Presentation, Unusual presentation of diffuse large B-cell lymphoma, Southern Society for Clinical Investigation, New Orleans, LA | 02/2007 |
| Scientific Presentations, Baker KS, Hassebroek A, Ballen K, Bigelow C, Frangoul H, Hardy, C, Lee S, Switzer G, Rizzo JD, Kein JP, Majhail N, Davies S, On behalf of the writing committee, Center for International Blood and Marrow Transplantation | 2007 |
| Scientific Presentations, Allotransplantation with reduced intensity conditioning that includes alemtuzumab lessens transplant-related mortality and incidence of relapse in patients with high-risk myeloid diseases, Southern Society for Clinical Investigation, Atlanta, Georgia | 03/2006 |
| Poster Presentation, Allotransplantation with reduced intensity conditioning that includes alemtuzumab lessens transplant-related mortality and incidence of relapse in patients with high-risk myeloid diseases, Tandem Bone Marrow Transplant Meetings, Honolulu, Hawaii | 02/2006 |
| Poster Presentation, Less transplant-related mortality with variable intensity conditioning than non-myeloablative conditioning in unrelated and related adult allogeneic transplant recipients, Tandem Bone Marrow Transplant Meetings, Keystone, Colorado | 02/2006 |
| State/Local Invited Seminars/Lectures, Variable Intensity Conditioning is Associated with Less Transplant Related Mortality than Non-myeloablative Conditioning in Unrelated and Related Allogeneic Transplant Recipients, University of Mississippi Medical Center Department of Medicine Research Day, Jackson, Mississippi | 05/2005 |
| Scientific Presentations, Variable Intensity Conditioning is Associated with Less Transplant Related Mortality than Non-myeloablative Conditioning in Unrelated and Related Allogeneic Transplant Recipients, Southern Society for Clinical Investigation, New Orleans, Louisiana | 02/2005 |
| Poster Presentation, Less Transplant-Related Mortality with Variable Intensity Conditioning than Non-myeloablative Conditioning in Unrelated and Related Adult Allogeneic Transplant Recipients, Tandem Bone Marrow Transplant Meetings, Keystone, Colorado | 02/2005 |
| Poster Presentation, Variable Intensity Conditioning is Associated with Less Transplant Related Mortality than Non-myeloablative Conditioning in Unrelated and Related Allogeneic Transplant Recipients, NMDP Annual Council Meeting, Minneapolis, Minnesota | 10/2004 |
| Invited Symposia, Complementary Therapies for Cancer: What Works, What Doesn’t, Cancer Conference held at First Baptist Church Christian Life Center, Jackson, Mississippi | 05/2004 |
| Poster Presentation, Variable Intensity Conditioning with Durable Engraftment and Less Graft Versus Host Disease in Recipients of Unrelated and Related Transplants, National Marrow Donor Program Annual Council Meeting, Minneapolis, Minnesota | 11/2003 |
| Invited Symposia, The Role of Hematopoietic Cell Transplantation in Sickle Cell Anemia, Sickle Cell Disease, Fourth Annual Education Seminar, Jackson, Mississippi | 09/2003 |
| Poster Presentation, Increased Incidence of Gastrointestinal Tract GVHD in Non-Myeloablated Recipients of Unrelated Donor Hematopoietic Cells, 2001 National Marrow Donor Program Council, Minneapolis, Minnesota | 11/2001 |
| Invited Symposia, Antifungal Preceptor Presenter, Pfizer Corporation, Jackson, Mississippi | 11/2001 |
| State/Local Invited Seminars/Lectures, Hodgkin’s Disease, Grand Rounds, University of Mississippi Medical Center, Jackson, Mississippi | 08/1997 |
| State/Local Invited Seminars/Lectures, National Marrow Donor Program - Becoming a Bone Marrow Donor, Lions Club, Canton, Mississippi | 01/1997 |
| State/Local Invited Seminars/Lectures, National Marrow Donor Program - Becoming a Bone Marrow Donor, Town Meeting, Yazoo City, Mississippi | 01/1997 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, Delta Regional Medical Center, Greenville, Mississippi | 09/1995 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, Oktibbeha County Hospital County Hospital, Starkville, Mississippi | 08/1995 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, Methodist Medical Center, Meridian, Mississippi | 08/1995 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, South Central Regional Medical Center, Laurel, Mississippi | 06/1995 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation Review and the UMC Experience, Grand Rounds, University of Mississippi Medical Center, Jackson, Mississippi | 03/1995 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, Jeff Anderson Regional Medical Center, Meridian, Mississippi | 01/1995 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, North Mississippi Medical Center, Tupelo, Mississippi | 10/1994 |
| State/Local Invited Seminars/Lectures, Primary Thrombocytosis: Diagnosis and Management, Grand Rounds, University of Mississippi Medical Center, Jackson, Mississippi | 01/1994 |
| State/Local Invited Seminars/Lectures, Chronic Leukemia, Internal Medicine Update, Natchez, Mississippi | 03/1993 |
| State/Local Invited Seminars/Lectures, Aplastic Anemia, Grand Rounds, University of Mississippi Medical Center, Jackson, Mississippi | 08/1992 |
| State/Local Invited Seminars/Lectures, Bone Marrow Transplantation, Grand Rounds, University of Mississippi Medical Center, Jackson, MS | 05/1989 |
| National and International Invited Seminars/Lectures, Successful Allogeneic Transplantation in the Rabbit, International Society of Experimental Hematology, Buffalo, New York | 1986 |
Honors, Awards, and Recognition
| Alpha Omega Alpha | |
| Graduated with Distinction | |
| Phi Beta Kappa |
Professional Membership and Service
| Southwest Oncology Group, Committee Member, Myeloma Committee, Lymphoma Committee | 1991 - Present |
| American Association of Blood Banks, Member | |
| American College of Physicians, Member | |
| American Federation for Clinical Research, Member | |
| American Medical Association, Member | |
| American Society for Blood and Marrow Transplantation, Member | |
| American Society of Hematology, Member | |
| Central Medical Society, Member | |
| International Society for Experimental Hematology, Member | |
| International Society for Hematology and Graft Engineering, Member | |
| Mississippi State Medical Association, Member | |
| Southern Association for Oncology, Member | |
| Southern Medical Assoication, Member | |
| Southern Society for Clinical Investigation, Member |
Committee Service
| Medical Center - Institutional Review Board 1, Member | 2007 - 2010 |
| Medical Center - Continuous Process Improvement Committee, National Marrow Donor Program, Member | 2002 - 2003 |
| Medical Center - Clinical Council Committee, Member | 1999 - 2008 |
| Medical Center - Pain Management Committee, Member | 1998 - Present |
| Medical Center - Chairman, Blood Transfusion Committee, Member | 1998 - 2002 |
| Medical Center - Executive hospital Committe, Member at Large, Member | 1993 - 1995 |
| The University Hospitals and Clinics - Blood Transfusion, Member | 1992 - 2002 |
| Medical Center - Clinical Practice Committee, Member | 1992 - 2000 |
| Medical Center - Health Futures Committee, Member | 1992 - 1995 |
| Medical Center - Southwest Oncology Group Myeloma Committe, Lymphoma Committee, Member | 1991 - Present |
| Medical Center - American Board of Internal Medicine Resident, Member | 1990 - 1995 |
| Medical Center - Executive Hospital Committe, Member | 1990 - 1992 |
Other Service
| Clinical Council Committee, Member | 1999 - 1999 |
| Pain Management Committee, Member | 1998 - Present |
| Secretary, Faculty Senate, Member | 1998 - 1999 |
| Senator, Faculty Senate, Member | 1997 - 2000 |
| Senator, Faculty Senate, Member | 1993 - 1995 |
| Clinical Practice Committee, Member | 1992 - 1992 |
Teaching Experience
| 621, Medicine, Lecture, Lecturer, Introduction to Clinical Medicine | Fall 2012 |
| 631, Medicine, Lecture, Lecturer, General Medicine Clerkship | Fall 2011 |
| 621, Medicine, Lecture, Lecturer, Introduction to Clinical Medicine | Fall 2011 |
| Medicine, Course, Lecturer, ICM Internal Medicine | Fall 2010 |
Fellows supervised
| Hematology/Oncology Fellowship Program, Attending Physician, 8 fellows supervised | 01/1988 - Present |
Residency Training
| Internal Medicine Residency, Attending Physician | 1988 - Present |